In 2026, the investment focus is shifting perceptibly. While AI remains the dominant growth story, real capital is increasingly flowing to where AI "touches the ground"—into electricity, grids, cooling systems, and physical infrastructure.

While technology stocks have dominated headlines, biotech is quietly positioning for one of its strongest years in a decade. Lower interest rates, a maturing pipeline of blockbuster GLP-1 obesity drugs, and AI transforming drug discovery are creating a perfect storm.

While tech stocks capture headlines and AI dominates investor conversations, a quieter but more profound transformation is unfolding across America's industrial heartland. Lower interest rates, tariff protection, and unprecedented infrastructure spending are fueling the strongest industrial expansion.

While public markets chase AI dreams and industrial steel, a parallel financial universe is exploding beneath the surface. Private credit has surged past $2 trillion in assets under management, surpassing hedge funds and rivaling traditional banks.

While mega-cap tech continues dominating headlines with trillion-dollar valuations, Wall Street's smartest money is quietly rotating into small-cap America. With the Russell 2000 up 28% YTD and trading at just 14x forward earnings, the valuation gap has reached levels not seen since 2009.